Zhang Nannan, Deng Jingyu, Sun Weilin, Du Yingxin, Guo Shiwei, Bai Huihui, Liu Huifang, Liang Han
Department of Gastroenterology, Tianjin Medical University Cancer Hospital, City Key Laboratory of Tianjin Cancer Center and National Clinical Research Center for Cancer, Tianjin 300060, China.
Ann Transl Med. 2020 Mar;8(6):376. doi: 10.21037/atm.2020.02.09.
Accumulating evidence confirms the potential prognostic value of extranodal soft tissue metastasis (ESTM) in patients with solid cancers. The aim of this study was to elucidate the potential relationship between ESTM and lymph node (LN) metastasis, demonstrate clinicopathological predictive prognostic factors for ESTM and LN metastasis, and identify the prognostic value of ESTM for gastric cancer (GC) patients aged under 70 years.
A total of 580 GC patients who underwent the curative resection between 2003 and 2011 were included to identify if ESTM is essential to improve the accuracy of prognostic evaluation of the GC patients postoperatively. Overall survival rates were tested by Kaplan-Meier analysis. Univariate and multivariate analyses were applied to clarify the independent prognostic factors. Logistic regression analysis was adopted to clarify the risk factors for evaluating the presence of ESTM and LN metastasis. After cut-point survival analysis, the GC patients were divided into three subgroups based on the number of ESTM and then incorporated into the pTNM stage of gastric carcinoma to identify the possibility and necessity of incorporating ESTM into staging.
ESTM was associated with advanced pT, pN and pTNM categories, large tumour size and the presence of signet-ring cell (SRC) variants. Survival analyses revealed that ESTM was associated with the OS and was an independent prognostic predictor in this GC patient cohort. Logistic regression analysis proved that ESTM and pT stage are significantly correlated with LN metastasis. Additionally, the ESTM was incorporated into the eighth edition of the pTNM classification and the prognostic evaluation of pTNME classification were calculated directly, and the results indicated that ESTM can reduce the stage migration.
ESTM is a significant independent predictor of survival in GC patients. To achieve R0 surgery, lymph nodes, soft tissues, fascia and adipose tissue should be resected en bloc at the same time as lymph node dissection. ESTM should be incorporated into pTNM staging according to the number retrieved from postoperative samples.
越来越多的证据证实了结外软组织转移(ESTM)在实体癌患者中的潜在预后价值。本研究的目的是阐明ESTM与淋巴结(LN)转移之间的潜在关系,论证ESTM和LN转移的临床病理预测预后因素,并确定ESTM对70岁以下胃癌(GC)患者的预后价值。
纳入2003年至2011年间接受根治性切除术的580例GC患者,以确定ESTM是否对提高GC患者术后预后评估的准确性至关重要。采用Kaplan-Meier分析检验总生存率。应用单因素和多因素分析来阐明独立预后因素。采用逻辑回归分析来阐明评估ESTM和LN转移存在的危险因素。经过切点生存分析后,根据ESTM的数量将GC患者分为三个亚组,然后纳入胃癌的pTNM分期,以确定将ESTM纳入分期的可能性和必要性。
ESTM与晚期pT、pN和pTNM分类、肿瘤体积大以及印戒细胞(SRC)变体的存在相关。生存分析显示,ESTM与总生存期相关,并且是该GC患者队列中的独立预后预测因素。逻辑回归分析证明,ESTM和pT分期与LN转移显著相关。此外,ESTM被纳入第八版pTNM分类,并直接计算pTNME分类的预后评估,结果表明ESTM可以减少分期迁移。
ESTM是GC患者生存的重要独立预测因素。为实现R0手术,应在淋巴结清扫的同时整块切除淋巴结、软组织、筋膜和脂肪组织。应根据术后样本中获取的数量将ESTM纳入pTNM分期。